z-logo
Premium
Purification and identification of angiotensin I‐converting enzyme‐inhibitory peptides from apalbumin 2 during simulated gastrointestinal digestion
Author(s) -
Xu Xiang,
Gao Yanxiang
Publication year - 2014
Publication title -
journal of the science of food and agriculture
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 142
eISSN - 1097-0010
pISSN - 0022-5142
DOI - 10.1002/jsfa.6755
Subject(s) - hydrolysate , peptide , digestion (alchemy) , biochemistry , size exclusion chromatography , enzyme , chemistry , hydrolysis , ic50 , amino acid , peptide sequence , chromatography , molecular mass , in vitro , biology , gene
BACKGROUND Bee larvae are considered to be an important reservoir for proteins. However, little attention has been paid to the release of potential bioactive peptides from bee larva proteins. In this study the major protein in bee larvae was hydrolyzed in vitro by gastrointestinal enzymes. The peptide profile of the hydrolysis was characterized by gel filtration chromatography and tricine‐ SDS‐PAGE . Furthermore, the bioactive peptide was isolated and identified by Q‐ TOF‐MS / MS . RESULTS The major bee larva protein was identified as apalbumin 2 and was more digestible into peptides with molecular weights lower than 3 kDa . The hydrolysate obtained after 3 h of digestion exhibited angiotensin I‐converting enzyme ( ACE )‐inhibitory activity and was purified sequentially by gel filtration and RP‐HPLC . The molecular weights of peptide fractions with ACE ‐inhibitory activity were distributed between 0.5 and 1.5 kDa . A novel peptide with highest ACE ‐inhibitory activity ( IC 50 54.9 µmol L −1 ) was purified by further RP‐HPLC . The amino acid sequence of this peptide was identified as LLKPY (632.40 Da). CONCLUSION ACE ‐inhibitory peptides could be formed from bee larvae through gastrointestinal digestion. The most active peptide ( LLKPY ) is potentially useful as a therapeutic agent in treating hypertension. © 2014 Society of Chemical Industry

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here